Qiagen NV reported $309.61M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Akebia Therapeutics USD 13.02M 22K Jun/2026
argenx SE USD 473.53M 132.91M Dec/2025
Avita Medical AUD 6.93M 614K Dec/2025
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Moderna USD 280M 134M Jun/2026
Organon & Co USD 1.35B 22M Jun/2026
Qiagen NV USD 309.61M 7.72M Mar/2026
Revvity USD 378.5M 9M Jun/2026
Viatris USD 3.93B 6.2M Jun/2026
Xeris Pharmaceuticals USD 80.93M 6.7M Jun/2026